Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of CBD on the GABAergic System in Patients with Fragile X Syndrome.

NCT06261450 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT06261450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06261450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of CBD on the GABAergic System in Patients with Fragile X Syndrome.
Lead sponsor
Université de Sherbrooke
Phase
Phase 2
Overall status
Not yet recruiting
Start date
May 1, 2025
Completion date
December 15, 2027
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fragile x syndrome